Today: 8 February 2026
Subscribe
Browse Category

NYSE:CAH News 4 December 2025 - 6 February 2026

Cardinal Health stock today: CAH slips in early trade after forecast hike

Cardinal Health stock today: CAH slips in early trade after forecast hike

Cardinal Health shares fell 0.2% to $226.66 Friday morning, despite raising its fiscal 2026 adjusted earnings forecast to $10.15-$10.35 per share after beating quarterly estimates. Second-quarter revenue rose 19% to $65.6 billion, with adjusted EPS at $2.63. CEO Jason Hollar cited strong specialty medicine demand but downplayed obesity drugs’ profit impact. Cencora rose 0.9%, McKesson slipped 0.4%.
6 February 2026
··
Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health shares jumped 9% to $226.05 Thursday after the company raised its fiscal 2026 adjusted earnings forecast to $10.15-$10.35 per share. Quarterly revenue rose 19% and adjusted profit beat estimates, driven by strong specialty drug demand. CEO Jason Hollar cited double-digit profit growth across all segments. Specialty medicines, including GLP-1 drugs, contributed significantly to revenue gains.
5 February 2026
····
Cardinal Health (CAH) Stock Pulls Back From Record Highs: Latest News, Forecasts and Investment Outlook as of December 3, 2025

Cardinal Health (CAH) Stock Pulls Back From Record Highs: Latest News, Forecasts and Investment Outlook as of December 3, 2025

Cardinal Health (NYSE: CAH) stock has cooled off after a powerful run in 2025, raising a key question for investors: is this just a healthy pullback, or the start of something more serious? Below is a detailed, news-driven look at Cardinal Health’s share price, fundamentals, analyst forecasts and key risks as of December 3, 2025. Cardinal Health Stock Today: Five Straight Losses After a Huge 2025 Rally At the close on Wednesday, December 3, 2025, Cardinal Health shares finished at $199.71, down 2.64% on the day. That decline came despite a positive session for the broader market, with the S&P
4 December 2025
·

Stock Market Today

Intel stock price jumps to $50: China CPU delays and SambaNova funding set up week ahead

Intel stock price jumps to $50: China CPU delays and SambaNova funding set up week ahead

8 February 2026
Intel shares rose 4.9% to $50.59 Friday, tracking a 5.7% jump in the PHLX semiconductor index as investors bet on AI-driven data-center spending. Reuters reported Intel and AMD warned Chinese customers of tighter server CPU supply, pushing Intel’s China prices up over 10%. Intel expects supply to improve in Q2. After the bell, Reuters said Intel plans to invest about $100 million in AI chip startup SambaNova Systems.
Go toTop